Open application window

DoW Multiple Sclerosis Clinical Trial Award deadline 2026

The current listed application deadline is August 12, 2026. Use this page to verify timing fast, then move into the full grant record for planning, comparison, and drafting.

Agency
Dept. of the Army -- USAMRAA
Award range
Not specified
Total funding
$4,000,000
Funding instrument
Grant
CFDA / ALN
12.420
Cost share
No

Application Countdown

93
Days
10
Hours
49
Minutes

Use this page as the fast check for timing, then jump into the full grant record for filters, drafting, and comparison.

Quick facts

Opportunity number
Not listed
Last updated
May 5, 2026
Expected awards
3

Deadline summary

Summary: The fiscal year 2026 (FY26) Multiple Sclerosis Research Program (MSRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis. All applications must address at least one of the FY26 MSRP CTA focus areas. Clinical trials may evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technol...

Key dates

Posted
May 4, 2026
Deadline
August 12, 2026

Before you apply

Confirm the official submission path and any portal requirements.
Review the close date carefully and account for agency timezone handling.
Validate fit against the listed eligibility groups before investing drafting time.
This program expects about 3 awards, which can help frame competitiveness.

Eligibility snapshot

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"